(Q48231744)

English

Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.

scientific article published on 27 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

type 2 diabetes

0 references

Carsten Dirksen

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

Jens Juul Holst

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

Christoffer Martinussen

object named as

Christoffer Martinussen

1

0 references

Nils B Jørgensen

object named as

Nils B Jørgensen

5

0 references

Kirstine N Bojsen-Møller

object named as

Kirstine N Bojsen-Møller

2

0 references

author name string

Siv H Jacobsen

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

Viggo B Kristiansen

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

publication date

27 January 2015

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

308

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

E535-44

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Role of glucose effectiveness in the determination of glucose tolerance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Increased hepatic insulin clearance after Roux-en-Y gastric bypass.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

ISEC: a program to calculate insulin secretion.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1 (GLP-1) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Methods for clinical assessment of insulin sensitivity and beta-cell function

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Banting lecture 1990. Beta-cells in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Short-term intensive insulin therapy in newly diagnosed type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Reduced insulin secretion by repeated low doses of STZ impairs glucose effectiveness but does not induce insulin resistance in dogs.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Use and abuse of HOMA modeling

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00506.2014

21 January 2018

Identifiers

10.1152/AJPENDO.00506.2014

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/25628424

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48231744&oldid=805915591"